Literature DB >> 22580623

Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.

A K Due1, I R Vogelius, M C Aznar, S M Bentzen, A K Berthelsen, S S Korreman, C A Kristensen, L Specht.   

Abstract

PURPOSE: Methods to estimate the likely origin of recurrences after radiation therapy for head and neck squamous cell carcinoma are compared. METHODS AND MATERIALS: A total of 25 patients meeting the following inclusion criteria were randomly selected: curatively intended intensity-modulated radiotherapy planned on a positron emission tomography-computed tomography (PET/CT) scan during the period 2005-2009; squamous cell carcinoma in the oral cavity, pharynx or larynx; complete clinical response followed by locoregional recurrence; and a CT scan at recurrence before any salvage therapy. Exclusion criteria were previous cancer in the area, surgery prior to radiotherapy, or a synchronous cancer. Three methods of estimating focal points of recurrence origin and two volume overlap methods assigning the recurrences to the most central target volumes encompassing at least 50% or 95% of the recurrence volumes were tested. Treatment planning and recurrence scans were rigid and deformable co-registered in order to transfer focal points to the treatment planning scan. Double determinations of all volumes, points, and co-registrations were made.
RESULTS: The volume overlap methods assigned the recurrences to significantly more peripheral target volumes than focal methods (p < 0.0001 for all comparisons of 95% overlap vs. focal methods, p < 0.028 for all comparisons of 50% overlap vs. focal methods). Repeated registrations of the same point had higher reproducibility with deformable registration than with rigid registration (median distance 0.31 vs. 0.35 cm, p = 0.015). No significant differences were observed among the focal methods.
CONCLUSION: Significant differences between methods were found which may affect strategies to improve radiotherapy based on pattern of failure analyses.

Entities:  

Mesh:

Year:  2012        PMID: 22580623     DOI: 10.1007/s00066-012-0127-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.

Authors:  Anne Kirkebjerg Due; Stine Korreman; Søren M Bentzen; Wolfgang Tomé; Edward Bender; Marianne Aznar; Ivan Vogelius; Anne K Berthelsen; Claus A Kristensen; Lena Specht
Journal:  Acta Oncol       Date:  2010-10       Impact factor: 4.089

2.  The reasons for discrepancies in target volume delineation : a SASRO study on head-and-neck and prostate cancers.

Authors:  Wendy Jeanneret-Sozzi; Raphaël Moeckli; Jean-François Valley; Abderrahim Zouhair; Esat Mahmut Ozsahin; René-Olivier Mirimanoff
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

3.  Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.

Authors:  Indira Madani; Wim Duthoy; Cristina Derie; Werner De Gersem; Tom Boterberg; Micky Saerens; Filip Jacobs; Vincent Grégoire; Max Lonneux; Luc Vakaet; Barbara Vanderstraeten; Wouter Bauters; Katrien Bonte; Hubert Thierens; Wilfried De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

4.  Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer.

Authors:  Gordon O Schoenfeld; Robert J Amdur; Christopher G Morris; Jonathan G Li; Russell W Hinerman; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

5.  Physical considerations on discrepancies in target volume delineation.

Authors:  Raphaël Moeckli; Wendy Jeanneret Sozzi; René-Olivier Mirimanoff; Mahmut Ozsahin; Abderrahim Zouhair; Jean-François Valley; François Bochud
Journal:  Z Med Phys       Date:  2009-07-07       Impact factor: 4.820

6.  Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial.

Authors:  Amira Shakam; Rufus Scrimger; Derek Liu; Mohamed Mohamed; Matthew Parliament; G Colin Field; Ali El-Gayed; Pat Cadman; Naresh Jha; Heather Warkentin; David Skarsgard; Qiaohao Zhu; Sunita Ghosh
Journal:  Radiother Oncol       Date:  2011-05-31       Impact factor: 6.280

7.  Validation of imaging with pathology in laryngeal cancer: accuracy of the registration methodology.

Authors:  Joana Caldas-Magalhaes; Nicolien Kasperts; Nina Kooij; Cornelis A T van den Berg; Chris H J Terhaard; Cornelis P J Raaijmakers; Marielle E P Philippens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-28       Impact factor: 7.038

8.  Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer.

Authors:  Julia Maurer; Matthias Hipp; Christof Schäfer; Oliver Kölbl
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

9.  Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.

Authors:  Stephen L Breen; Julia Publicover; Shiroma De Silva; Greg Pond; Kristy Brock; Brian O'Sullivan; Bernard Cummings; Laura Dawson; Anne Keller; John Kim; Jolie Ringash; Eugene Yu; Aaron Hendler; John Waldron
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

10.  Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.

Authors:  Dirk Rades; Thekla Meyners; Nadja Kazic; Amira Bajrovic; Volker Rudat; Steven E Schild
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

View more
  17 in total

1.  Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.

Authors:  Abdallah S R Mohamed; Carlos E Cardenas; Adam S Garden; Musaddiq J Awan; Crosby D Rock; Sarah A Westergaard; G Brandon Gunn; Abdelaziz M Belal; Ahmed G El-Gowily; Stephen Y Lai; David I Rosenthal; Clifton D Fuller; Michalis Aristophanous
Journal:  Radiother Oncol       Date:  2017-07-31       Impact factor: 6.280

Review 2.  Computerized PET/CT image analysis in the evaluation of tumour response to therapy.

Authors:  W Lu; J Wang; H H Zhang
Journal:  Br J Radiol       Date:  2015-02-27       Impact factor: 3.039

3.  Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy.

Authors:  Gregor Heiduschka; Anja Grah; Felicitas Oberndorfer; Lorenz Kadletz; Gabriela Altorjai; Gabriela Kornek; Fritz Wrba; Dietmar Thurnher; Edgar Selzer
Journal:  Strahlenther Onkol       Date:  2014-09-25       Impact factor: 3.621

4.  Open source deformable image registration system for treatment planning and recurrence CT scans : Validation in the head and neck region.

Authors:  Ruta Zukauskaite; Carsten Brink; Christian Rønn Hansen; Anders Bertelsen; Jørgen Johansen; Cai Grau; Jesper Grau Eriksen
Journal:  Strahlenther Onkol       Date:  2016-06-20       Impact factor: 3.621

Review 5.  Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician.

Authors:  Jolien Heukelom; Clifton David Fuller
Journal:  Semin Radiat Oncol       Date:  2019-07       Impact factor: 5.934

6.  Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.

Authors:  Stefan Huttenlocher; Nina D Seibold; Maximilian P Gebhard; Frank Noack; Christoph Thorns; Katrin Hasselbacher; Barbara Wollenberg; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2014-06-14       Impact factor: 3.621

7.  Quality assurance assessment of diagnostic and radiation therapy-simulation CT image registration for head and neck radiation therapy: anatomic region of interest-based comparison of rigid and deformable algorithms.

Authors:  Abdallah S R Mohamed; Manee-Naad Ruangskul; Musaddiq J Awan; Charles A Baron; Jayashree Kalpathy-Cramer; Richard Castillo; Edward Castillo; Thomas M Guerrero; Esengul Kocak-Uzel; Jinzhong Yang; Laurence E Court; Michael E Kantor; G Brandon Gunn; Rivka R Colen; Steven J Frank; Adam S Garden; David I Rosenthal; Clifton D Fuller
Journal:  Radiology       Date:  2014-11-07       Impact factor: 11.105

8.  Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.

Authors:  Anne K Due; Ivan R Vogelius; Marianne C Aznar; Søren M Bentzen; Anne K Berthelsen; Stine S Korreman; Annika Loft; Claus A Kristensen; Lena Specht
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280

9.  Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.

Authors:  N D Seibold; S E Schild; M P Gebhard; F Noack; U Schröder; D Rades
Journal:  Strahlenther Onkol       Date:  2013-05-24       Impact factor: 3.621

10.  Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  D Rades; N D Seibold; M P Gebhard; F Noack; K L Bruchhage; S E Schild
Journal:  Strahlenther Onkol       Date:  2013-07-18       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.